Home » Topics » BioWorld Science

BioWorld Science
RSS

EPRS inhibitor DWN-12088 shows antifibrotic effects in vitro and in vivo

Sep. 15, 2021

Preclinical data presented for HIF-1 inhibitor LW-1564

Sep. 15, 2021

Kinnate presents preclinical data on next-generation pan-FGFR inhibitor KIN-3248

Sep. 14, 2021

Satellos reports preclinical data on drug candidate in mouse model of DMD

Sep. 14, 2021

Strong nectin-4 expression tied to poor prognosis in UTUC

Sep. 14, 2021

SQZ announces celiac disease as first autoimmune clinical translation of TAC platform

Sep. 14, 2021

vTv Therapeutics discloses glucokinase activators

Sep. 14, 2021

Beta Pharma presents new GTPase KRAS mutant inhibitors

Sep. 14, 2021

Tempest Therapeutics licenses intellectual property to cancer target from University of California

Sep. 14, 2021

Discovery of apigenin derivative with potential to overcome drug-resistant MET-mutant RCC

Sep. 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...